FTDI
GMAB icon

First Trust Direct Indexing’s Genmab GMAB Stock Holding History

First Trust Direct Indexing’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,045
Closed -$288K – 833
2023
Q4 		$288K Sell
9,045
-6,709
-43% -$211K 0.03% 596
2023
Q3 		$556K Sell
15,754
-1,232
-7% -$46.9K 0.06% 361
2023
Q2 		$646K Buy
16,986
+508
+3% +$20.3K 0.07% 329
2023
Q1 		$622K Buy
16,478
+1,091
+7% +$41.9K 0.07% 334
2022
Q4 		$652K Buy
15,387
+637
+4% +$26.2K 0.09% 304
2022
Q3 		$474K Buy
14,750
+3,887
+36% +$136K 0.07% 353
2022
Q2 		$353K Buy
10,863
+809
+8% +$26.2K 0.05% 422
2022
Q1 		$364K Buy
10,054
+3,104
+45% +$107K 0.04% 446
2021
Q4 		$275K Sell
6,950
-51
-0.7% -$2.13K 0.04% 515
2021
Q3 		$306K Buy
7,001
+738
+12% +$33.1K 0.04% 469
2021
Q2 		$256K Buy
+6,263
New +$242K 0.04% 501
2021
Q1 		– Sell
-1,036
Closed -$42K – 627
2020
Q4 		$42K Buy
+1,036
New +$38.7K 0.01% 789

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Direct Indexing's GMAB Position: Q1 2024 in Review

First Trust Direct Indexing sold out of Genmab (GMAB) in Q1 2024, closing a stake of 9,045 shares — an estimated $288K sold.

First Trust Direct Indexing first reported a position in GMAB in Q4 2020 and held it in 12 quarters. The position peaked at $652K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • First Trust Direct Indexing reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 9,045 Genmab shares in Q1 2024, an estimated $288K.
  • First Trust Direct Indexing first reported a position in Genmab in Q4 2020 and held it in 12 quarters.
  • First Trust Direct Indexing's Genmab position peaked at $652K in Q4 2022.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on First Trust Direct Indexing's 13F filing for Q1 2024, filed 19 Apr 2024.